US Physicians Throw A Legal Hail Mary

After five years and over three million dollars in legal fees, US physicians were handed an adverse and controversial split decision by the United States Court of Appeals for the Seventh Circuit regarding the antitrust aspects of the proprietary American Board of Medical Specialties’ Maintenance of Certification (MOC) product.

In response, on Thursday the Plaintiffs in the case filed a petition for rehearing en banc that was accepted. A rehearing en banc is a procedure where a case is reheard by all the judges of a particular circuit court of appeals, not just the three-judge panel that initially heard it. This is a rare procedure, typically granted when a case is of exceptional importance or to resolve a conflict in the circuit’s own precedent. Such a rehearing is not a standard part of the appeals process and is only granted in limited circumstances, often when a case has exceptional importance, raises significant legal questions, or where a panel’s decision conflicts with another panel’s ruling within the same circuit. By granting the rehearing en banc, it automatically vacates the previous decision of the three-judge panel. The case is then reviewed by the full court, which may decide it based on the existing briefs or order new briefing. 

I encourage all physicians to read the entire rehearng petition linked above. It clearly outlines flaws in the Majority’s decision and outlines the many ways physicians view MOC as a competitor in the CME market for state licensure. For now, the case is NOT over and with a bit of luck and appropriate administration of justice, has the potential to turn the tide on the ABMS MOC monopoly that is adversely impacting US physicians nationwide.

Westby Fisher, MD, Co-founder, Practicing Physicians of America

MOC: Still Too Big to Fail

On 30 October 2025, the Court of Appeals for the Seventh District Circuit Court rendered its opinion on the Lazarou v American Board of Psychiatry and Neurology (ABPN) antitrust case (24-1994) involving the American Board of Medical Specialties’ (ABMS) Maintenance of Certification (MOC) program. The results, in a word, were laughable but entirely predictable. 

This antitrust appeal asked the Court to decide whether the American Board of Psychiatry and Neurology (“ABPN”) is causing unfair competition in the continuing medical education market. The psychiatrists who brought this suit alleged that ABPN uses its monopoly over specialty certifications to force them to purchase ABPN’s “maintenance of certification” product. In their 51-page appeal, the plaintiffs argued that ABPN’s MOC product is a substitute for other CME offerings, which they had to prove to establish their case. The court found their theories unconvincing, stating that MOC’s requirements impose additional burdens on doctors and therefore cannot substitute for CME, concluding that “they have failed to plausibly allege that doctors see ABPN’s MOC product as reasonably interchangeable with CME,” and dismissed the case with prejudice.

Of course, the court’s circular reasoning is precisely the point: MOC is more burdensome (and costly) than self-selected CME for physicians, largely because the Boards have an admitted monopoly (Page 16 of the Opinion) on physician certification and MOC’s construct. To make matters worse, the Accreditation Council of Graduate Medical Education (ACGME)-accredited hospital systems have quietly tied MOC to physicians’ ability to secure admitting privileges and insurance payments. Is there any surprise then that organizations who benefit financially from MOC (like the American Hospital Association, American Medical Association, and ABMS) are member organizations of the ACGME?

We should note that during oral arguments, the Court adjusted the oral argument schedule at the last minute to be sure the same judge (Scudder) that ruled on the earlier Siva v American Board of Radiology antitrust case heard the Lazarou v ABPN arguments. And like the earlier antitrust case brought before it in 2022 (Siva v the American Board of Radiology) , the Board’s argument was given very short shrift in the Court’s opinion and a new reason to dismiss advanced by the Appeals Court.

The dissenting judge Maldonado’s full statement is noteworthy and is summarized very briefly here: “I am concerned with the continuous heightening of the pleading standards for antitrust claims in this circuit. This trend produces more prolix complaints filed with factual allegations that apparently still don’t make the cut for suggesting liability.” Further, she adds “the majority’s decision to affirm dismissal of Plaintiff’s complaint, even in light of amendments tailored to (the prior anti-trust case) Siva (v Am Board of Radiology) amounts to changing the goal posts in the middle of the game.”

What This Means Going Forward

Like releasing the Epstein Files, this case highlights that exposing even the slightest hint of MOC’s true intent, conflicts of interest, and inner workings must never be breached, even to the point of raising the bar of antitrust law requirements to find liability, lest it threaten cornerstones of the entire Medical Industrial Complex. The adverse effects of the ABMS MOC continuous certification program, like fraud, discrimination, and the like on health care costs, physician retention, physician access, physician burnout, and ability of physicians to serve as independent patient advocates must never be taken seriously. 

For Physicians, What Now?

For physicians looking at less compromised employment opportunities, I would suggest they carefully consider Direct Patient Care models that are not subject to ABMS oversight or employment at institutions that accept the National Board of Physicians and Surgeons (NBPAS) re-certification pathway using self-selected CME for state licensure and hospital credentials. For physicians already employed at institutions that ONLY accept ABMS recertification for hospital privileging that want to avoid MOC they either must retire, change employment to a non-ABMS requiring institution, or not question the payments and busy-work mandated by the ABMS MOC monopoly to retain employment or hospital admitting privileges. Still, I would still encourage those physicians to ALSO hold NBPAS re-certification to help support that organization’s rising effort to disrupt the unproven ABMS MOC “continuous certification” monopoly.

-Westby Fisher, MD, Cofounder, Practicing Physician of America

MOC and the Antitrust Oral Arguments in Lazarou v ABPN

On January 15, 2025, oral arguments were made before the 7th Circuit Appellate Court in Chicago regarding the Lazarou v American Board of Psychiatry and Neurology (ABPN) (24-1994). Both attorneys for the Plaintiffs and ABPN presented their points to the judges. A link to the full transcript of those proceedings is provided here. In summary,

  • Mr. Curley (Attorney for the Plaintiffs) argued that the ABPN’s MOC product meets the criteria established in the SIVA case for being part of the CME market. He emphasized that the MOC product contains educational content, allows doctors to earn CME credits, and is accepted by states for licensure purposes. ​ He also pointed out that the MOC product can substitute for other CME products, thus impacting competition.
  • Mr. Sullivan (Attorney for ABPN) countered that the ABPN does not produce or sell CME products and does not compete in the CME market. ​ He argued that the differences highlighted by Mr. Curley are not legally significant and that the ABPN’s MOC requirements do not foreclose competition in the CME market.

The judges asked probing questions to both sides, indicating that they were considering the arguments carefully. Ultimately, the decision on which argument is more compelling will be made by the court after taking the appeal under advisement.

Thanks to all who helped support this ongoing legal effort against MOC.

Hoping for A Christmas Miracle for All US Physicians

Imagine an end to the forced participation in the American Board of Medical Specialties (ABMS) trademarked Maintenance of Certification (MOC) program required by all US academic (and many non-academic) hospital systems in the United States. Ending the unproven MOC program’s constant threat of loss of employment because of failure to make a MOC payment to one of the 24 member boards of the ABMS, or because of failure to participate in their repeated online or in-person testing has seemed impossible.

Until now.

January 15, 2025 is the date set for oral arguments before the 7th Circuit Court of Appeals in Chicago in Lazarou v ABPN (No. 24-1994) antitrust case. If the judges rule favorably in the Plaintiffs’ favor, the complaint will finally go to discovery and jury trial. This case, if won, would set a precedent to legally challenge MOC for each of the other 23 member boards of the ABMS.

But all of us need to do our part. To put it bluntly, it will take a little bit of cash to help make this happen. About $11,000 more added to the GoFundMe page created for the legal efforts underway is needed for additional preparatory legal work. Depending on how many physicians give, that might be as little needed as $1 or $5 per doctor.

Please don’t turn away. Give now. Even the smallest donation can make a huge difference, Please help us bring this lengthy legal effort to fruition.

Thank you and

Merry Christmas and Happy Holidays.

Wes Fisher, MD

Latest Updates on MOC Antitrust Lawsuit Appeal

Following dismissal of their antitrust lawsuit against the American Board of Psychiatry and Neurology (ABPN) regarding Maintenance of Certification (MOC) in May 2024, Emily Elizabeth Lazarou, MD and Aafaque Akhter, MD appealed their case to  the United States Court of Appeals for the Seventh Circuit. What follows is an artificial intelligence-generated review of where that appeal stands, using an Adobe AI Assistant to simplify understanding of the arguments pleaded so far by both sides.


The issue statement in the appeal brief filed by the plaintiffs is:

“Whether the District Court erred in dismissing Plaintiffs’ tying claims when it found Plaintiffs failed to plausibly allege that Defendant-Appellee American Board of Psychiatry and Neurology’s (“ABPN”) maintenance of certification (“MOC”) product is a continuing medical education (“CME”) product.” ​

The main arguments presented by the plaintiffs are:

  1. MOC as a CME Product: The plaintiffs argue that the Maintenance of Certification (MOC) product offered by the American Board of Psychiatry and Neurology (ABPN) is a Continuing Medical Education (CME) product. ​ They claim that MOC contains educational content, provides CME credits for state licensure, and is not redundant of other CME requirements. ​
  2. Substitutability of MOC: The plaintiffs assert that MOC is a substitute for other CME products. ​ They argue that doctors use MOC to meet state CME licensure requirements, and that MOC provides CME credits directly through the AMA and is accepted by many states in place of CME requirements.
  3. Antitrust Standing: The plaintiffs claim they have antitrust standing because they are directly affected by the alleged tying arrangement. ​ They argue that the tying of MOC to initial certification by ABPN restricts competition in the CME market, forcing doctors to purchase MOC instead of other CME products. ​
  4. Economic Impact: The plaintiffs allege that ABPN’s tying arrangement has led to a significant increase in MOC revenue and a decline in the number of CME providers, indicating a substantial foreclosure of competition in the CME market. ​
  5. Request for Leave to Amend: If the court finds that specific evidentiary details about individual state CME requirements should have been included in the complaint, the plaintiffs request leave to amend the complaint to provide such details. ​
  6. Reinstatement of Unjust Enrichment Claim: The plaintiffs argue that upon reinstatement of their Sherman Act claims, their unjust enrichment claim should also be reinstated, as it is related to the same set of facts and legal issues.

The American Board of Psychiatry and Neurology (ABPN) responded with several key arguments to support the dismissal of the plaintiffs’ case:

  1. Stare Decisis: ABPN argues that the doctrine of stare decisis, which mandates adherence to previous court decisions, forecloses this suit. ​ The case at hand is materially identical to the Siva v. American Board of Radiology case, which was dismissed by the Seventh Circuit. ​ Therefore, the same reasoning should apply, and the dismissal should be upheld. ​
  2. False Equivalence: ABPN contends that the plaintiffs’ legal theory is based on a logical fallacy of false equivalence. ​ The plaintiffs incorrectly equate the Maintenance of Certification (MOC) program with Continuing Medical Education (CME) products. ​ MOC is a comprehensive program with multiple requirements, not just a collection of CME credits. ​ Therefore, MOC cannot be considered a substitute for CME products. ​
  3. Lack of Substitution: ABPN argues that MOC is not a substitute for CMEs. ​ The plaintiffs fail to plausibly allege cross-price elasticity, which would show that MOC and CMEs are reasonably interchangeable in the minds of relevant consumers. ​ Additionally, MOC is not required for state licensure, and many states prohibit considering MOC for licensure maintenance. ​
  4. No Financial Interest in CME Products: ABPN highlights that it has no financial interest in any accredited CME products. ​ The MOC program requires diplomates to purchase CME products from other providers, and ABPN does not produce or have a financial stake in these products.
  5. Lack of Coercion or Force: ABPN asserts that the plaintiffs have not plausibly alleged actual coercion or force. ​ The adverse consequences of not maintaining board certification are imposed by third parties, such as hospitals and insurance companies, not by ABPN itself. ​ Therefore, there is no illegal tying. ​
  6. Non-Competitor in CME Market: ABPN argues that it is not a competitor in the CME market. ​ The plaintiffs’ own contentions that MOC is effectively useless and not valued by physicians confirm that MOC does not compete on the merits in the CME market. ​
  7. Denial of Leave to Amend: ABPN contends that the district court did not abuse its discretion in refusing to allow the plaintiffs to file a fourth complaint. ​ The plaintiffs had multiple opportunities to state a claim and failed to do so. ​ The district court provided a reasonable explanation for the dismissal with prejudice. ​

In summary, ABPN’s arguments focus on the application of stare decisis, the logical fallacy in the plaintiffs’ claims, the lack of substitution and financial interest, the absence of coercion, and the non-competitive nature of MOC in the CME market. ​ These points collectively support the dismissal of the plaintiffs’ case.


The subsequent reply brief by the Plaintiffs to ABPN’s arguments explains that the doctrine of stare decisis is inapplicable in this case because the Second Amended Complaint (SAC) contains substantial new factual allegations that address specific concerns raised in the prior decision, Siva v. American Board of Radiology. ​ The brief argues that stare decisis applies only to legal determinations made in prior precedential opinions and does not apply to issues of fact or new information that were not part of the previous decision. ​ The brief cites several cases to support this argument, emphasizing that stare decisis is limited to legal issues actually decided in a prior action and does not extend to different facts or new records. ​ The brief also distinguishes the current case from the Third Circuit’s non-precedential Kenney opinion, noting that the SAC includes new allegations not considered in Kenney and that Kenney’s analysis was contrary to the Seventh Circuit’s holding in Viamedia v Comcast (7th Cir 2020). ​

The reply brief outlines several new factual allegations included in the Second Amended Complaint (SAC) that address the concerns raised in the prior decision, Siva v. American Board of Radiology. ​ These new allegations are:

  1. Educational Content: The SAC alleges that Maintenance of Certification (MOC) has educational content, which was not sufficiently detailed in the previous complaint. ​
  2. CME Credit: The SAC includes allegations that doctors can earn Continuing Medical Education (CME) credits from MOC, which can be used for state licensure requirements. ​
  3. Non-Redundancy: The SAC asserts that MOC is not redundant of other CME requirements, addressing the concern that MOC simply imposes a redundant obligation to buy other CME products. ​
  4. Substitutability: The SAC provides detailed allegations showing that MOC is a substitute for other CME products, including that doctors view MOC and other CME products interchangeably and that MOC serves the same purpose as other CME products. ​
  5. Market Demand: The SAC includes allegations that MOC and other CME products are reasonably interchangeable in the minds of relevant consumers, permitting an inference of cross-price elasticity between MOC and other CME offerings. ​
  6. State Acceptance: The SAC details how many states accept MOC in full or partial satisfaction of CME requirements for licensure, and that MOC can be used to meet state CME requirements. ​
  7. Economic Impact: The SAC alleges that the number of accredited providers of continuing medical education has declined significantly since the advent of MOC, indicating a substantial foreclosure of competition in the CME market. ​

These new allegations aim to address the deficiencies identified in the Siva decision and provide a more robust basis for the plaintiffs’ claims. ​ The new factual allegations are significant for several reasons:

  1. Addressing Pleading Deficiencies: The new allegations directly address the deficiencies identified in the prior decision, Siva v. American Board of Radiology. ​ By including detailed facts about the educational content of MOC, the ability to earn CME credits from MOC, and the non-redundancy of MOC with other CME requirements, the plaintiffs aim to meet the pleading standards required to survive a motion to dismiss.
  2. Establishing Substitutability: The new allegations provide a basis for arguing that MOC is a substitute for other CME products. ​ This is crucial for establishing that MOC and other CME products are part of the same relevant product market, which is necessary for the plaintiffs’ tying claim. ​
  3. Demonstrating Market Impact: By alleging that MOC has led to a significant decline in the number of accredited CME providers and that MOC is accepted by many states for licensure requirements, the plaintiffs aim to show that MOC has a substantial impact on the CME market. This supports their argument that ABPN’s practices have anticompetitive effects. ​
  4. Countering Stare Decisis: The new factual allegations help to counter the defendant’s argument that the doctrine of stare decisis should apply. ​ By presenting new and specific facts that were not considered in the previous case, the plaintiffs argue that the current case is materially different and should not be bound by the prior decision. ​
  5. Supporting Economic Realities: The allegations about the economic necessity of certification for hospital privileges, insurance, and employment help to explain why ABPN’s conditioning of certification on the purchase of MOC constrains doctors’ choices. ​ This supports the plaintiffs’ claim of “forcing” in the context of an illegal tying arrangement. ​

Overall, the new factual allegations strengthen the plaintiffs’ case by providing a more detailed and robust foundation for their claims, addressing the concerns raised in the prior decision, and demonstrating the anticompetitive impact of ABPN’s practices. ​


The ABPN still has on opportunity to respond the plaintiff’s reply brief before the case goes to oral arguments.

According to the court docket, oral arguments will occur sometime after 12 Dec 2024 when the Plaintiff’s attorney is available. We hope to update US physicians when those arguments are scheduled.


Contributions to support these updates and the legal effort underway to end MOC’s stranglehold on US physicians are still being accepted. Please give generously to our ongoing GoFundMe campaign.